| Tyyppi : |
Lehti |
|
| Tutkimus Joukkueet : |
Mac Gaw Park - American Critical Care |
| Tekijät : |
Lee YC, Baaske DM, Amann AH, Carter JE, Mooers MA, Wagenknecht DM, Lai CM. |
| Otsikko : |
Bretylium tosylate intravenous admixture compatibility. I: Stability in common large-volume parenteral solutions. |
| Numero : |
Am J Hosp Pharm ; 37: 803-808. 1980 |
|
| Todisteiden määrä : |
|
| Fyysinen vakaus : |
|
| Kemiallinen stabiilisuus : |
|
| Muut menetelmät : |
|
| Commentairesvaleur : |
|
Luettelo yhdisteistä
 Bretylium tosilate
|
 |
 |
 |
 |
10 mg/ml |
25°C |
 |
| 48 |
 |
|
|
|
|
|
10 mg/ml |
40°C |
 |
| 48 |
|
|
|
|
|
|
10 mg/ml |
4°C |
|
| 7 |
 |
|
|
|
|
 |
10 mg/ml |
25°C |
|
| 48 |
|
|
|
|
|
|
10 mg/ml |
40°C |
|
| 48 |
|
|
|
|
|
|
10 mg/ml |
4°C |
|
| 7 |
|
|
|
|
 |
|
10 mg/ml |
25°C |
|
| 48 |
|
|
|
|
|
|
10 mg/ml |
40°C |
|
| 48 |
|
|
|
|
|
|
10 mg/ml |
4°C |
|
| 7 |
|
|
|
|
|
|
10 mg/ml |
25°C |
|
| 48 |
|
|
|
|
|
|
10 mg/ml |
40°C |
|
| 48 |
|
|
|
|
|
|
10 mg/ml |
4°C |
|
| 7 |
|
|
|
|
|
